ArticleACG case reports journal2025

Transient Visual Loss due to Infliximab Administration: A New Adverse Event to Biologic Therapy in Crohn's Disease.

Henrique Coelho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.